Edition:
United States

People: Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

1,984.85INR
22 Aug 2017
Change (% chg)

-- (--)
Prev Close
Rs1,984.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
48,660
52-wk High
Rs3,394.95
52-wk Low
Rs1,901.65

Prasad, G. 

Mr. G. V. Prasad is Co-Chairman of the Board, Chief Executive Officer, Managing Director of Dr. Reddy’s Laboratories Limited since May 2014. He leads the core team at Dr. Reddy’s that has contributed signifi cantly to its transformation from a mid-sized domestic operation into a global pharmaceutical major. He is the architect of Dr. Reddy’s successful Global Generics and Active Pharmaceutical Ingredient (API) strategies, as well as the Company’s foray into Biosimilars and Differentiated Formulations. Mr. Prasad is engaged in strengthening the Company’s research and development capabilities, supporting progressive people practices and building a holistic culture of operational excellence. He was declared India’s Best CEO in the Large Company category by Business Today in 2014, and India Business Leader of the Year by CNBC Asia in 2015. Mr. Prasad holds a degree in Chemical Engineering from the Illinois Institute of Technology, Chicago, USA and a Masters in Industrial Administration from Purdue University, USA.

Basic Compensation

Total Annual Compensation, INR 116,990,000
Restricted Stock Awards, INR --
Long-Term Incentive Plans, INR --
All Other, INR 2,230,000
Fiscal Year Total, INR 119,220,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Satish Reddy

88,030,000

G. Prasad

119,220,000

Saumen Chakraborty

39,930,000

Sripada Chandrasekhar

--

Abhijit Mukherjee

14,600,000

Amit Biswas

--
As Of  30 Mar 2016